OMCL Logo

Omnicell, Inc. (OMCL) 

NASDAQ
Market Cap
$2.4B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
651 of 776
Rank in Industry
25 of 32

Largest Insider Buys in Sector

OMCL Stock Price History Chart

OMCL Stock Performance

About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software …

Insider Activity of Omnicell, Inc.

Over the last 12 months, insiders at Omnicell, Inc. have bought $0 and sold $0 worth of Omnicell, Inc. stock.

On average, over the past 5 years, insiders at Omnicell, Inc. have bought $150,479 and sold $14.17M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,000 shares for transaction amount of $295,040 was made by LIPPS RANDALL A (CHAIRMAN, PRESIDENT AND CEO) on 2023‑06‑08.

List of Insider Buy and Sell Transactions, Omnicell, Inc.

2023-06-09SaleEVP, EXECUTIVE ADVISOR
7,951
0.0179%
$73.14$581,568-52.09%
2023-06-08PurchaseCHAIRMAN, PRESIDENT AND CEO
4,000
0.0089%
$73.76$295,040-52.90%
2023-03-07Saledirector
9,797
0.0219%
$53.97$528,718+0.99%
2023-03-07Saledirector
13,115
0.0295%
$54.24$711,333+0.99%
2022-12-27SaleEVP, CHIEF COMMERCIAL OFFICER
945
0.0022%
$48.28$45,625+19.04%
2022-12-16SaleEVP, CHIEF COMMERCIAL OFFICER
4,436
0.0098%
$47.79$211,990+14.94%
2022-12-01SaleCHAIRMAN, PRESIDENT AND CEO
2,500
0.0056%
$50.78$126,942+9.91%
2022-11-28SaleEVP, CHIEF COMMERCIAL OFFICER
1,793
0.0043%
$51.46$92,268+15.18%
2022-08-26SaleEXECUTIVE V P& CFO
15,481
0.0349%
$108.29$1.68M-43.96%
2022-08-22SaleEXECUTIVE V P& CFO
11,000
0.0246%
$105.93$1.17M-42.41%
2022-08-16SaleCHAIRMAN, PRESIDENT AND CEO
13,000
0.0292%
$111.04$1.44M-44.04%
2022-06-15SaleEVP, CHIEF COMMERCIAL OFFICER
3,208
0.0071%
$110.01$352,912-42.32%
2022-03-14SaleEVP, Chief Commercial Officer
2,525
0.0058%
$133.11$336,103-25.23%
2021-12-16SaleEVP, Chief Commercial Officer
3,628
0.0083%
$176.90$641,778-36.55%
2021-12-16SaleEVP & Chief Legal & Admin
1,063
0.0024%
$176.88$188,019-36.55%
2021-12-08SaleChief Accounting Officer & VP
6,976
0.0158%
$180.76$1.26M-38.34%
2021-12-07SaleExecutive V P& CFO
8,517
0.0196%
$181.15$1.54M-37.50%
2021-12-07SaleChief Accounting Officer & VP
1,179
0.0027%
$181.14$213,564-37.50%
2021-11-16SaleChief Accounting Officer & VP
38,585
0.0879%
$180.36$6.96M-36.31%
2021-11-02SaleEVP & Chief Legal & Admin
5,358
0.0125%
$180.00$964,440-33.71%

Insider Historical Profitability

0.32%
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEO
318768
0.6931%
$52.222173<0.0001%
WHITTERS JOSEPH Edirector
38886
0.0845%
$52.2224+36.39%
Seim Robin GeneDirector
30049
0.0653%
$52.22154+11.39%
LINDHOLM RANDY Ddirector
27763
0.0604%
$52.22414<0.0001%
YOUNGER WILLIAM H JRdirector
20860
0.0454%
$52.22315<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$234.03M17.438.01M+1.51%+$3.49M0.01
The Vanguard Group$165.2M12.315.65M+1.44%+$2.35M<0.01
Cadian Capital Management LP$67.83M5.052.32M+3,470.11%+$65.93M2.41
State Street$59.9M4.462.05M+1.83%+$1.08M<0.01
Champlain Investment Partners, LLC$51.25M3.821.75M+15.96%+$7.05M0.29
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.